Michigan Taco Bells have stopped serving lettuce, cilantro
The Great Lakes State has reported over 1,000 cases of cyclosporiasis, a parasitic foodborne illness, but it’s not clear if the outbreak is tied to Taco Bell. Continue reading →
Cloudflare Precursor uses continuous behavioral analysis to stop advanced bots
Cloudflare has announced the general availability of Precursor, a next-generation, continuous behavioral validation engine for bot management. Precursor runs seamlessly inside web browsers to monitor entire user sessions in order to detect bot automation. Unlike static CAPTCHAs, it analyzes...
EU and UK blacklist Russia’s cyber operators over efforts to destabilize Europe
The EU and the UK jointly sanctioned dozens of Russian individuals and entities, accusing Moscow of coordinating a malicious cyber ecosystem targeting Europe, its member states, and international partners. The UK sanctioned 24 individuals and entities, while the EU imposed restrictive measures...![<![CDATA[DTP is Scaling Fast, the Safety Infrastructure is Not]]>](https://theindustryexpert.com/wp-content/uploads/2026/07/d1c150efe7de32ab97164f5ea3f8e517de7a036e-1280x811-1.jpg)
<![CDATA[DTP is Scaling Fast, the Safety Infrastructure is Not]]>
Continue reading →![<![CDATA[FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab ]]>](https://theindustryexpert.com/wp-content/uploads/2026/07/0dbf0cb40e19992ded21dba032cdc788e977ba7a-1280x720-1.jpg)
Fresh ATM Crypto Software Bugs: Jackpot or Bust?
Organizations, and possibly ATMs, are at risk of compromise, thanks to holes in a Microsoft BitLocker security wrapper. Continue reading →
Cybercriminals Flock to Healthcare Businesses as Attacks Surge
While cyberattacks against hospitals and clinics grew modestly in the first half of 2026, attacks on service providers and other healthcare businesses more than doubled. Continue reading →
Halma acquires pathology automation specialist Dreampath
Halma has agreed to acquire French diagnostics company Dreampath in a deal that will expand its pathology portfolio and strengthen technologies supporting tissue sample management. The acquisition includes an initial cash payment of €154m, with additional performance-related payments of up to...
ReproNovo Phase 2 fertility study doses first participant
ReproNovo has dosed the first participant in its phase 2 NORDIC study evaluating RPN-002, an investigational therapy designed to improve embryo implantation during assisted reproductive technology (ART). The randomised, double-blind, placebo-controlled trial will enrol 120 participants across...